When pictilisib is coupled with anastrozole for treating patients with HR+/HER2- early breast cancer, it can significantly inhibit tumour cell proliferation52, but there is no superior benefit when pictilisib is combined with paclitaxel or fulvestrant53,.54 This evidence concerns the gene ERBB2 and breast carcinoma.